Core Insights - Park Ha (PHH) opened with a significant increase of 24.45%, reaching a stock price of $0.82 per share, with a trading volume of $1.3684 million and a total market capitalization of $21.6244 million [1] Financial Performance - As of October 31, 2024, Park Ha reported total revenue of 2.3819 million RMB, reflecting a year-on-year decrease of 3.14% [1] - The net profit attributable to the parent company was 478,600 RMB, showing a substantial year-on-year decline of 43.83% [1] Company Overview - Park Ha Biotechnology Co., Ltd. is a Cayman Islands-registered holding company primarily operated by its domestic entity, Jiangsu Park Ha Biotechnology Co., Ltd. [1] - The company's business focuses on developing its own skincare brand, direct selling skincare products, and promoting franchise alliances [1] - The "Park Ha" brand specializes in providing solutions for problematic skin, established in 2016, with its first store opening in 2017 [1] Franchise Operations - As of April 30, 2024, and October 31, 2023, the company had 43 and 38 franchisees in China, respectively, compared to 49 franchisees in 2022 [1] - Among these, 41, 36, and 45 franchisees operated under the "Park Ha" brand name in the respective years [1]
朴荷上涨24.45%，报0.82美元/股，总市值2162.44万美元